1
Tarran Jones
Roger A Sabbadini, William A Garland, Genevieve Hansen, Steven Tarran Jones, David Gareth Williams: Compositions and methods for binding sphingosine-1-phosphate. Lpath, BioTechnology Law Group, Daniel M Chambers, November 9, 2010: US07829674 (4 worldwide citation)

The present invention relates to anti-S1P agents, for example, humanized monoclonal antibodies, and their uses for detection of S1P or for treatment of diseases and conditions associated with S1P.


2
Tarran Jones
Roger A Sabbadini, William A Garland, Genevieve Hansen, Steven Tarran Jones, David Gareth Williams: Compositions and methods for binding sphingosine-1-phosphate. Lpath, Acuity Law Group P C, Daniel M Chambers, September 27, 2011: US08026342 (1 worldwide citation)

The present invention relates to anti-S1P agents, for example, humanized monoclonal antibodies, and their uses for detection of S1P or for treatment of diseases and conditions associated with S1P.


3

4
Sabbadini Roger A, Garland William A, Hansen Genevieve, Jones Steven Tarran, Williams David Gareth: Compositions and methods for binding sphingosine-1-phosphate. Lpath Therapeutics, Sabbadini Roger A, Garland William A, Hansen Genevieve, Jones Steven Tarran, Williams David Gareth, CHAMBERS Daniel M, June 12, 2008: WO/2008/070344 (9 worldwide citation)

The present invention relates to anti-SIP agents, for example, humanized monoclonal antibodies, and their uses for detection of SIP or for treatment of diseases and conditions associated with SIP.


5
Tarran Jones
Sabbadini Roger A, Garland William A, Hansen Genevieve, Jones Steven Tarran, Williams David Gareth: Compositions and methods for binding sphingosine-1-phosphate. Lpath Therapeutics, Wu Guimeng, Zhang Yang, March 24, 2010: CN200780048665

The present invention relates to anti-SIP agents, for example, humanized monoclonal antibodies, and their uses for detection of SIP or for treatment of diseases and conditions associated with SIP.


6

7

8
Tarran Jones
Roger A SABBADINI, William A GARLAND, Genevieve HANSEN, Steven Tarran JONES, David WILLIAMS: Compositions and methods for binding sphingosine-1-phosphate. Biotechnology Law Group, c o Portfolioip, January 8, 2009: US20090010922-A1

The present invention relates to anti-S1P agents, for example, humanized monoclonal antibodies, and their uses for detection of S1P or for treatment of diseases and conditions associated with S1P.


9
Tarran Jones
Roger A SABBADINI, William A GARLAND, Genevieve HANSEN, Steven Tarran JONES, David Gareth Williams: Compositions and methods for binding sphingosine-1-phosphate. BioTechnology Law Group, January 7, 2010: US20100003242-A1

The present invention relates to anti-S1P agents, for example, humanized monoclonal antibodies, and their uses for detection of S1P or for treatment of diseases and conditions associated with S1P.


10
[ZH] 用于结合鞘氨醇-1-磷酸的组合物和方法, [EN] COMPOSITIONS AND METHODS FOR BINDING SPHINGOSINE-1-PHOSPHATE. May 27, 2015: CN137654066

[EN] The present invention relates to anti-SIP agents, for example, humanized monoclonal antibodies, and their uses for detection of SIP or for treatment of diseases and conditions associated with SIP.